This week, direct-to-patient healthcare company Ro made it easier for those patients to find where to get their meds with the launch of the GLP-1 Supply Tracker, an interactive tool that provides real-time insights on GLP-1 drug shortages, along with automated, localized supply alerts
Cardiovascular efficacy and safety are currently being assessed in a dedicated outcomes trial
others sell the medication almost alone
Their serum and treatment category also gives me a useful signal about their commercial orientation
We're seeing the same patterns across every pathway we work in
Reported forms include research powder, oral capsules, and transdermal preparations (often DMSO-based), and the oral-versus-transdermal debate in forums frequently repeats the now-retracted claim that Dihexa is reliably brain-penetrant when taken orally